Change in human papillomavirus prevalence among U.S. women aged 18-59 years, 2009-2014

Obstetrics and Gynecology

Volumn 130, Issue 4, 2017, Pages 693-701

  Berenson, Abbey B ^a   Hirth, Jacqueline M ^a   Chang, Mihyun ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; CHLAMYDIA; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GONORRHEA; GROUPS BY AGE; HERD IMMUNITY; HERPES SIMPLEX VIRUS 2; HUMAN; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; UNITED STATES; VACCINATION; WART VIRUS; NUTRITION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; STATISTICS AND NUMERICAL DATA; VAGINA; VIROLOGY; YOUNG ADULT;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNITY, HERD; MIDDLE AGED; NUTRITION SURVEYS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PREVALENCE; UNITED STATES; VACCINATION; VAGINA; YOUNG ADULT;

EID: 85030616620     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000002193     Document Type: Article

References (9)

1. Berenson AB, Laz TH, Rahman M. Reduction in vaccine-Type human papillomavirus prevalence among women in the United States, 2009-2012. J Infect Dis 2016; 214: 1961-4.
2. Markowitz LE, Liu G, Hariri S, Steinau M, Dunne EF, Unger ER. Prevalence of HPV after introduction of the vaccination program in the United States. Pediatrics 2016; 137: e20151968.
3. Tarney CM, Klaric J, Beltran T, Pagan M, Han J. Prevalence of human papillomavirus in self-collected cervicovaginal swabs in young women in the United States between 2003 and 2012. Obstet Gynecol 2016; 128: 1241-1247.
4. Centers for Disease Control and Prevention, National Center for Health Statistics. National Health and Nutrition Examination Survey Data. Available at: https://wwwn.cdc.gov/nchs/nhanes/Default.aspx. Retrieved January 2, 2017.
5. Markowitz LE, Hariri S, Lin C, Dunne EF, Steinau M, McQuillan G, et al. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. J Infect Dis 2013; 208: 385-93.
6. Kahn JA, Brown DR, Ding L, Widdice LE, Shew ML, Glynn S, et al. Vaccine-Type human papillomavirus and evidence of herd protection after vaccine introduction. Pediatrics 2012; 130: e249-56.
7. Rahman M, McGrath CJ, Hirth JM, Berenson AB. Age at HPV vaccine initiation and completion among US adolescent girls: trend from 2008 to 2012. Vaccine 2015; 33: 585-7.
8. Centers for Disease Control and Prevention (CDC). Noninfluenza vaccination coverage among adults-United States, 2011. MMWR Morb Mortal Wkly Rep 2013; 62: 66-72.
9. Hirth J, Kuo YF, Laz TH, Starkey JM, Rupp RE, Rahman M, et al. Concordance of adolescent human papillomavirus vaccination parental report with provider report in the National Immunization Survey-Teen (2008-2013). Vaccine 2016; 34: 4415-21.